论文部分内容阅读
１９９３年２月至１９９４年１２月对８７例食管癌患者进行大剂量短程术前放疗，８６例做了食管癌切除颈部Ｇａｍｂｅｅ＇ｓ吻合术，１例单纯探查（Ⅰ组）。同期食管癌患者９９例，行单纯手术治疗（Ⅱ组），作为对照组。放疗方法：２０～２５ＧＹ／４～５次／４～５天，放疗后１～７天行手术治疗。结果：全部患者均可耐受大剂量放疗。术中见肿瘤变软、缩小；手术出血量、手术时间、术后并发症与对照组相比无明显差异。手术切除率：Ⅰ组９９％（８６／８７），Ⅱ组８９％（８８／９９），Ｐ＜０．０５。手术死亡率：Ⅰ组０，Ⅱ组２％（２／９９）。术后生存率：１年Ⅰ组６８．６％（５９／８６），Ⅱ组６４．８％（５７／８８）；２年Ⅰ组５０．０％（４３／８６），Ⅱ组４６．６％（４１／８８）；３年Ⅰ组４６．９％（１５／３２），Ⅱ组３７．５％（１２／３２）。
From February 1993 to December 1994, 87 cases of esophageal cancer were treated with high-dose short-range preoperative radiotherapy, 86 cases had undergone Gambe’s anastomosis of the neck of esophageal cancer, and 1 case of simple exploration (group I). In the same period, 99 patients with esophageal cancer underwent surgery alone (Group II) as a control group. Radiotherapy: 20 ~ 25GY / 4 ~ 5 times / 4 ~ 5 days, 1 ~ 7 days after radiotherapy surgery. Results: All patients can tolerate high-dose radiation therapy. During surgery, the tumor became soft and narrow; there was no significant difference in the amount of blood loss, operation time, and postoperative complications compared with the control group. The surgical resection rate was 99% (86/87) in group I and 89% (88/99) in group II, P<0.05. Surgical mortality: I group 0, II group 2% (2/99). Postoperative survival rate: 68.6% (59/86) in group I for 1 year, 64.8% (57/88) in group II, 50.0% (43/86) in group 2 for 2 years, and group 46.6 in group 2 % (41/88); 46.9% (15/32) in group I for 3 years and 37.5% (12/32) in group II.